IMPACT ON ITALIAN NATIONAL HEALTH SERVICE EXPENDITURE FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM WITH RIVAROXABAN

被引：0
|
作者：
Roggeri, A. [1 ]
Roggeri, D. P. [1 ]
Pengo, V [2 ]
机构：
[1] ProCure Solut, Nembro, BG, Italy
[2] Univ Hosp Padova, Padua, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.829
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV60
引用
收藏
页码：A384 / A384
页数：1
相关论文
共 50 条
  • [31] BUDGET IMPACT MODEL (BIM) OF RIVAROXABAN IN COMPARISON WITH ENOXAPARIN PLUS WARFARIN IN THE TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) UNDER THE PERSPECTIVE OF THE PRIVATE HEALTH SYSTEM
    Piedade, A.
    Paladini, L.
    Tobaruella, F.
    Nakada, C.
    VALUE IN HEALTH, 2015, 18 (07) : A383 - A384
  • [32] Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J'xactly study
    Migita, Shohei
    Okumura, Yasuo
    Fukuda, Ikuo
    Nakamura, Mashio
    Yamada, Norikazu
    Takayama, Morimasa
    Maeda, Hideaki
    Yamashita, Takeshi
    Ikeda, Takanori
    Mo, Makoto
    Yamazaki, Tsutomu
    Hirayama, Atsushi
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [33] Patterns and Predictors of Use of Anticoagulants for the Treatment of Venous Thromboembolism Following Approval of Rivaroxaban
    Dault, Roxanne
    Vanasse, Alain
    Blais, Lucie
    Perreault, Sylvie
    Farand, Paul
    Le Templier, Genevieve
    Beauchesne, Marie-France
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (08) : 765 - 771
  • [34] Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism
    Simon Mantha
    Jack Ansell
    Journal of Thrombosis and Thrombolysis, 2015, 39 : 155 - 165
  • [35] The use of rivaroxaban for short- and long-term treatment of venous thromboembolism
    Cohen, Alexander T.
    Dobromirski, Mark
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (06) : 1035 - 1043
  • [36] Impact of austerity programs: Evidence from the Italian national health service
    Chisari, Giorgio
    Lega, Federico
    HEALTH SERVICES MANAGEMENT RESEARCH, 2023, 36 (02) : 145 - 152
  • [37] Variation in Plasma Levels of Apixaban and Rivaroxaban in Clinical Routine Treatment of Venous Thromboembolism
    Reda, Sara
    Rudde, Eva
    Mueller, Jens
    Hamedani, Nasim Shahidi
    Oldenburg, Johannes
    Poetzsch, Bernd
    Ruehl, Heiko
    LIFE-BASEL, 2022, 12 (05):
  • [38] Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
    Shohei Migita
    Yasuo Okumura
    Ikuo Fukuda
    Mashio Nakamura
    Norikazu Yamada
    Morimasa Takayama
    Hideaki Maeda
    Takeshi Yamashita
    Takanori Ikeda
    Makoto Mo
    Tsutomu Yamazaki
    Atsushi Hirayama
    Thrombosis Journal, 21
  • [39] Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry
    Speed, Victoria
    Auyeung, Vivian
    Patel, Jignesh P.
    Cooper, Derek
    Miller, Stephen
    Roberts, Lara N.
    Patel, Raj K.
    Arya, Roopen
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (08)
  • [40] Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism
    Coleman, Craig I.
    Bunz, Thomas J.
    Turpie, Alexander G. G.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (10) : 1841 - 1847
12345